Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Fusobacterium nucleatum | 15 | 2021 | 160 | 4.370 |
Why?
|
Colorectal Neoplasms | 33 | 2024 | 6754 | 2.730 |
Why?
|
Fatty Acids, Volatile | 7 | 2021 | 101 | 2.060 |
Why?
|
Colitis | 11 | 2023 | 1149 | 1.980 |
Why?
|
Gastrointestinal Tract | 9 | 2016 | 814 | 1.980 |
Why?
|
Intestinal Mucosa | 12 | 2022 | 3038 | 1.820 |
Why?
|
Metagenome | 10 | 2021 | 417 | 1.800 |
Why?
|
Bacteria | 13 | 2023 | 2102 | 1.740 |
Why?
|
Colonic Neoplasms | 12 | 2024 | 2542 | 1.630 |
Why?
|
Receptors, G-Protein-Coupled | 6 | 2021 | 1221 | 1.460 |
Why?
|
Symbiosis | 5 | 2019 | 283 | 1.400 |
Why?
|
Immunity, Mucosal | 4 | 2020 | 491 | 1.350 |
Why?
|
Colon | 10 | 2021 | 1773 | 1.190 |
Why?
|
T-Box Domain Proteins | 6 | 2015 | 471 | 1.110 |
Why?
|
Escherichia coli | 6 | 2023 | 4214 | 0.970 |
Why?
|
Dendritic Cells | 12 | 2020 | 2723 | 0.800 |
Why?
|
Dietary Fiber | 4 | 2021 | 760 | 0.780 |
Why?
|
Tryptophanase | 1 | 2020 | 6 | 0.780 |
Why?
|
Homeostasis | 8 | 2022 | 3335 | 0.730 |
Why?
|
Eosinophils | 2 | 2022 | 953 | 0.700 |
Why?
|
Fusobacterium Infections | 4 | 2021 | 53 | 0.690 |
Why?
|
Tretinoin | 1 | 2022 | 516 | 0.690 |
Why?
|
Enterobacteriaceae | 2 | 2010 | 169 | 0.680 |
Why?
|
Lactococcus lactis | 2 | 2016 | 28 | 0.670 |
Why?
|
Enterococcus | 1 | 2020 | 158 | 0.660 |
Why?
|
Inflammatory Bowel Diseases | 7 | 2022 | 2410 | 0.650 |
Why?
|
Bacteroides fragilis | 1 | 2019 | 212 | 0.640 |
Why?
|
Butyrates | 1 | 2019 | 163 | 0.640 |
Why?
|
Muramidase | 4 | 2015 | 174 | 0.620 |
Why?
|
Intestines | 3 | 2012 | 1923 | 0.600 |
Why?
|
Tumor Microenvironment | 12 | 2024 | 3564 | 0.600 |
Why?
|
Gram-Positive Bacterial Infections | 1 | 2020 | 341 | 0.590 |
Why?
|
Th17 Cells | 2 | 2021 | 765 | 0.590 |
Why?
|
Interleukin-17 | 2 | 2021 | 900 | 0.580 |
Why?
|
Interleukins | 2 | 2020 | 791 | 0.580 |
Why?
|
Bifidobacterium | 3 | 2021 | 100 | 0.570 |
Why?
|
Intestine, Small | 2 | 2020 | 1243 | 0.550 |
Why?
|
Chemoreceptor Cells | 1 | 2016 | 86 | 0.540 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 7 | 2021 | 1038 | 0.540 |
Why?
|
Intestinal Diseases, Parasitic | 1 | 2016 | 66 | 0.540 |
Why?
|
Quorum Sensing | 1 | 2016 | 131 | 0.530 |
Why?
|
Immunity, Innate | 4 | 2019 | 2956 | 0.530 |
Why?
|
Animals | 55 | 2023 | 168561 | 0.520 |
Why?
|
Dietary Proteins | 1 | 2020 | 963 | 0.520 |
Why?
|
Adenoma | 4 | 2021 | 2168 | 0.510 |
Why?
|
Mice | 39 | 2023 | 81045 | 0.510 |
Why?
|
TRPM Cation Channels | 1 | 2016 | 140 | 0.510 |
Why?
|
Colitis, Ulcerative | 5 | 2011 | 1901 | 0.490 |
Why?
|
Malnutrition | 1 | 2021 | 625 | 0.490 |
Why?
|
Epithelial Cells | 4 | 2022 | 3678 | 0.480 |
Why?
|
Interferon Type I | 1 | 2017 | 542 | 0.460 |
Why?
|
Kwashiorkor | 1 | 2013 | 24 | 0.460 |
Why?
|
Chemokine CCL2 | 1 | 2015 | 617 | 0.430 |
Why?
|
Superoxide Dismutase | 1 | 2015 | 596 | 0.430 |
Why?
|
Mice, Knockout | 14 | 2020 | 14554 | 0.420 |
Why?
|
Protein Processing, Post-Translational | 1 | 2020 | 1989 | 0.420 |
Why?
|
Feces | 9 | 2021 | 1394 | 0.420 |
Why?
|
Lymphocytes | 1 | 2019 | 2614 | 0.400 |
Why?
|
Diet | 9 | 2021 | 7923 | 0.400 |
Why?
|
Aspirin | 2 | 2021 | 3278 | 0.390 |
Why?
|
Anti-Infective Agents | 1 | 2019 | 971 | 0.390 |
Why?
|
Metagenomics | 6 | 2022 | 430 | 0.390 |
Why?
|
Diseases in Twins | 1 | 2013 | 450 | 0.390 |
Why?
|
Proteus mirabilis | 1 | 2010 | 25 | 0.380 |
Why?
|
Mice, Inbred BALB C | 9 | 2020 | 6382 | 0.380 |
Why?
|
Germ-Free Life | 4 | 2021 | 188 | 0.370 |
Why?
|
Proteome | 1 | 2020 | 1790 | 0.370 |
Why?
|
Microbial Interactions | 1 | 2010 | 76 | 0.360 |
Why?
|
Mood Disorders | 1 | 2017 | 1106 | 0.360 |
Why?
|
Immunity | 1 | 2016 | 1011 | 0.360 |
Why?
|
Receptors, Cell Surface | 1 | 2019 | 2867 | 0.360 |
Why?
|
Disease Models, Animal | 12 | 2020 | 18006 | 0.360 |
Why?
|
Escherichia coli Proteins | 1 | 2016 | 1052 | 0.350 |
Why?
|
Insulin-Secreting Cells | 1 | 2017 | 891 | 0.350 |
Why?
|
Gastroenteritis | 2 | 2019 | 245 | 0.350 |
Why?
|
Inflammation | 5 | 2021 | 10578 | 0.340 |
Why?
|
Klebsiella pneumoniae | 1 | 2010 | 246 | 0.330 |
Why?
|
Tritrichomonas | 2 | 2020 | 3 | 0.330 |
Why?
|
Gastrointestinal Diseases | 1 | 2017 | 1167 | 0.320 |
Why?
|
Humans | 84 | 2024 | 742088 | 0.320 |
Why?
|
Graft vs Host Disease | 2 | 2020 | 2951 | 0.310 |
Why?
|
Milk | 1 | 2010 | 449 | 0.300 |
Why?
|
T-Lymphocytes | 5 | 2021 | 10163 | 0.290 |
Why?
|
Taste | 2 | 2020 | 175 | 0.290 |
Why?
|
DNA-Binding Proteins | 7 | 2015 | 9639 | 0.290 |
Why?
|
Renal Insufficiency, Chronic | 1 | 2020 | 2195 | 0.280 |
Why?
|
Influenza, Human | 1 | 2017 | 1472 | 0.280 |
Why?
|
Immune System | 3 | 2023 | 804 | 0.270 |
Why?
|
Interleukin-13 | 2 | 2020 | 389 | 0.270 |
Why?
|
Adenocarcinoma | 4 | 2016 | 6347 | 0.270 |
Why?
|
Antigen Presentation | 6 | 2003 | 1284 | 0.270 |
Why?
|
Probiotics | 3 | 2021 | 351 | 0.260 |
Why?
|
STAT3 Transcription Factor | 3 | 2020 | 874 | 0.260 |
Why?
|
Disease Susceptibility | 4 | 2021 | 1780 | 0.250 |
Why?
|
Kidney | 1 | 2020 | 7167 | 0.250 |
Why?
|
Mice, Inbred C57BL | 12 | 2021 | 21821 | 0.250 |
Why?
|
Hematopoietic Stem Cell Transplantation | 2 | 2020 | 5425 | 0.240 |
Why?
|
Immunomodulation | 2 | 2019 | 540 | 0.240 |
Why?
|
Sulfur | 2 | 2021 | 166 | 0.230 |
Why?
|
Feeding Behavior | 4 | 2021 | 3187 | 0.230 |
Why?
|
Neoplasms | 4 | 2023 | 21596 | 0.230 |
Why?
|
Tumor Escape | 2 | 2017 | 349 | 0.230 |
Why?
|
DNA Contamination | 1 | 2023 | 19 | 0.230 |
Why?
|
Hydrogen Sulfide | 2 | 2021 | 137 | 0.220 |
Why?
|
Diabetes Mellitus, Type 1 | 1 | 2017 | 3336 | 0.220 |
Why?
|
Biomass | 1 | 2023 | 125 | 0.210 |
Why?
|
Microsatellite Instability | 4 | 2020 | 678 | 0.210 |
Why?
|
Citrobacter rodentium | 1 | 2022 | 65 | 0.210 |
Why?
|
T-Lymphocytes, Regulatory | 2 | 2013 | 2986 | 0.210 |
Why?
|
Genome, Bacterial | 3 | 2019 | 754 | 0.210 |
Why?
|
Host-Pathogen Interactions | 6 | 2016 | 1477 | 0.200 |
Why?
|
Mouth | 3 | 2020 | 373 | 0.200 |
Why?
|
Sulfur-Reducing Bacteria | 1 | 2021 | 16 | 0.200 |
Why?
|
Fermentation | 2 | 2013 | 143 | 0.200 |
Why?
|
Sulfur Compounds | 1 | 2021 | 31 | 0.200 |
Why?
|
Dextran Sulfate | 2 | 2020 | 236 | 0.200 |
Why?
|
Indican | 1 | 2020 | 17 | 0.190 |
Why?
|
Toxins, Biological | 1 | 2020 | 66 | 0.190 |
Why?
|
Gene Expression Regulation, Bacterial | 3 | 2016 | 1119 | 0.190 |
Why?
|
Adenomatous Polyps | 1 | 2021 | 107 | 0.190 |
Why?
|
Nematospiroides dubius | 1 | 2020 | 35 | 0.180 |
Why?
|
Bacterial Proteins | 4 | 2022 | 3843 | 0.180 |
Why?
|
Carcinoma | 3 | 2017 | 2374 | 0.180 |
Why?
|
Strongylida Infections | 1 | 2020 | 46 | 0.180 |
Why?
|
DNA, Bacterial | 4 | 2018 | 1465 | 0.180 |
Why?
|
Glycogen | 1 | 2020 | 260 | 0.180 |
Why?
|
cdc42 GTP-Binding Protein | 1 | 2000 | 194 | 0.170 |
Why?
|
CD8-Positive T-Lymphocytes | 3 | 2020 | 4438 | 0.170 |
Why?
|
RNA, Ribosomal, 16S | 4 | 2020 | 947 | 0.170 |
Why?
|
Campylobacter Infections | 1 | 2019 | 32 | 0.170 |
Why?
|
Campylobacter | 1 | 2019 | 59 | 0.170 |
Why?
|
Bifidobacteriales Infections | 1 | 2018 | 10 | 0.170 |
Why?
|
Adenomatous Polyposis Coli Protein | 1 | 2020 | 188 | 0.170 |
Why?
|
Mitochondria, Muscle | 1 | 2020 | 171 | 0.170 |
Why?
|
Activating Transcription Factor 6 | 1 | 2018 | 28 | 0.170 |
Why?
|
Conservation of Natural Resources | 1 | 2021 | 205 | 0.160 |
Why?
|
DNA Adducts | 1 | 2019 | 93 | 0.160 |
Why?
|
Mutagens | 1 | 2019 | 168 | 0.160 |
Why?
|
Specimen Handling | 2 | 2021 | 692 | 0.160 |
Why?
|
Escherichia coli Infections | 1 | 2022 | 532 | 0.160 |
Why?
|
Cell Transformation, Neoplastic | 2 | 2021 | 2940 | 0.160 |
Why?
|
Carcinoma, Signet Ring Cell | 1 | 2018 | 83 | 0.160 |
Why?
|
Fatty Acids, Nonesterified | 1 | 2020 | 402 | 0.160 |
Why?
|
Permeability | 1 | 2020 | 738 | 0.150 |
Why?
|
Physical Endurance | 1 | 2020 | 370 | 0.150 |
Why?
|
Endocytosis | 3 | 2002 | 983 | 0.150 |
Why?
|
Fusobacterium | 2 | 2021 | 54 | 0.150 |
Why?
|
Reactive Oxygen Species | 2 | 2015 | 2077 | 0.150 |
Why?
|
Cyclopropanes | 1 | 2019 | 416 | 0.150 |
Why?
|
Macrophages | 3 | 2024 | 5655 | 0.150 |
Why?
|
Ileum | 1 | 2020 | 565 | 0.150 |
Why?
|
Phylogeny | 5 | 2019 | 2797 | 0.140 |
Why?
|
Disease Progression | 3 | 2020 | 13256 | 0.140 |
Why?
|
Cultured Milk Products | 1 | 2016 | 6 | 0.140 |
Why?
|
Nursing Research | 1 | 2017 | 77 | 0.140 |
Why?
|
Flagella | 1 | 2016 | 101 | 0.140 |
Why?
|
Virulence | 2 | 2019 | 1328 | 0.140 |
Why?
|
Colonic Polyps | 1 | 2021 | 542 | 0.140 |
Why?
|
Protozoan Infections | 1 | 2016 | 39 | 0.140 |
Why?
|
Transducin | 1 | 2016 | 46 | 0.140 |
Why?
|
Helminths | 1 | 2016 | 35 | 0.140 |
Why?
|
Antigens, Tumor-Associated, Carbohydrate | 1 | 2016 | 134 | 0.140 |
Why?
|
Food | 1 | 2021 | 769 | 0.140 |
Why?
|
Calcium, Dietary | 1 | 2019 | 527 | 0.140 |
Why?
|
Adhesins, Bacterial | 1 | 2016 | 119 | 0.140 |
Why?
|
Colorectal Neoplasms, Hereditary Nonpolyposis | 1 | 2020 | 379 | 0.130 |
Why?
|
Catecholamines | 1 | 2016 | 387 | 0.130 |
Why?
|
Biological Evolution | 2 | 2013 | 1074 | 0.130 |
Why?
|
Receptors, Pattern Recognition | 1 | 2016 | 78 | 0.130 |
Why?
|
Helminthiasis | 1 | 2016 | 66 | 0.130 |
Why?
|
Fetus | 1 | 2023 | 1879 | 0.130 |
Why?
|
Bacterial Adhesion | 1 | 2016 | 316 | 0.130 |
Why?
|
Pathology, Molecular | 1 | 2018 | 325 | 0.120 |
Why?
|
Pseudomonas putida | 1 | 2014 | 46 | 0.120 |
Why?
|
Male | 31 | 2023 | 349538 | 0.120 |
Why?
|
Cell Biology | 1 | 2015 | 92 | 0.120 |
Why?
|
Female | 33 | 2023 | 379592 | 0.120 |
Why?
|
Benzoic Acid | 1 | 2014 | 15 | 0.120 |
Why?
|
Anti-Bacterial Agents | 3 | 2019 | 7153 | 0.120 |
Why?
|
Calcium Signaling | 1 | 2019 | 721 | 0.120 |
Why?
|
Precancerous Conditions | 1 | 2021 | 971 | 0.120 |
Why?
|
Lectins | 1 | 2016 | 514 | 0.120 |
Why?
|
Bradyrhizobium | 1 | 2013 | 19 | 0.120 |
Why?
|
Interferon-gamma | 1 | 2022 | 3199 | 0.120 |
Why?
|
Anopheles | 1 | 2016 | 197 | 0.120 |
Why?
|
Th1 Cells | 1 | 2019 | 1056 | 0.120 |
Why?
|
Antimetabolites, Antineoplastic | 1 | 2017 | 640 | 0.120 |
Why?
|
Cytokines | 3 | 2019 | 7317 | 0.120 |
Why?
|
Receptors, Antigen, T-Cell, gamma-delta | 1 | 2015 | 341 | 0.110 |
Why?
|
Microbial Consortia | 1 | 2013 | 32 | 0.110 |
Why?
|
Gene Expression Regulation | 4 | 2015 | 12071 | 0.110 |
Why?
|
Adaptation, Physiological | 1 | 2020 | 1310 | 0.110 |
Why?
|
Seafood | 1 | 2016 | 384 | 0.110 |
Why?
|
Deoxycytidine | 1 | 2017 | 824 | 0.110 |
Why?
|
Immunotherapy | 3 | 2021 | 4414 | 0.110 |
Why?
|
Bone Development | 1 | 2016 | 483 | 0.110 |
Why?
|
Anticarcinogenic Agents | 1 | 2015 | 253 | 0.110 |
Why?
|
Goblet Cells | 1 | 2016 | 287 | 0.110 |
Why?
|
Cardiovascular System | 1 | 2020 | 827 | 0.110 |
Why?
|
Carbohydrate Metabolism | 1 | 2014 | 264 | 0.110 |
Why?
|
Epithelium | 1 | 2017 | 1680 | 0.110 |
Why?
|
Biomedical Research | 2 | 2021 | 3306 | 0.110 |
Why?
|
Mucous Membrane | 2 | 2013 | 670 | 0.110 |
Why?
|
T-Lymphocyte Subsets | 1 | 2021 | 1837 | 0.110 |
Why?
|
Prospective Studies | 14 | 2022 | 53187 | 0.110 |
Why?
|
Mice, Mutant Strains | 1 | 2016 | 1866 | 0.110 |
Why?
|
Tumor Necrosis Factor-alpha | 3 | 2023 | 4414 | 0.110 |
Why?
|
Bacterial Physiological Phenomena | 1 | 2013 | 122 | 0.110 |
Why?
|
Fatty Acids | 2 | 2020 | 1806 | 0.100 |
Why?
|
Liver Neoplasms | 2 | 2023 | 4249 | 0.100 |
Why?
|
Autophagy | 1 | 2020 | 1301 | 0.100 |
Why?
|
Acetylglucosamine | 1 | 2013 | 191 | 0.100 |
Why?
|
Nod2 Signaling Adaptor Protein | 1 | 2011 | 87 | 0.100 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2019 | 2502 | 0.090 |
Why?
|
Chromosomes, Mammalian | 1 | 2011 | 151 | 0.090 |
Why?
|
Myeloid Cells | 1 | 2015 | 804 | 0.090 |
Why?
|
Opportunistic Infections | 1 | 2013 | 389 | 0.090 |
Why?
|
Adaptive Immunity | 1 | 2015 | 712 | 0.090 |
Why?
|
Histocompatibility Antigens Class II | 4 | 2003 | 1470 | 0.090 |
Why?
|
Immune System Phenomena | 1 | 2009 | 16 | 0.090 |
Why?
|
Mycoses | 1 | 2013 | 376 | 0.090 |
Why?
|
Antimicrobial Cationic Peptides | 1 | 2012 | 362 | 0.090 |
Why?
|
Bartholin's Glands | 1 | 2008 | 5 | 0.080 |
Why?
|
Crohn Disease | 2 | 2019 | 2301 | 0.080 |
Why?
|
Colonoscopy | 1 | 2017 | 1365 | 0.080 |
Why?
|
Lysosomes | 3 | 2003 | 893 | 0.080 |
Why?
|
DNA Damage | 1 | 2019 | 2423 | 0.080 |
Why?
|
Incidence | 7 | 2021 | 20928 | 0.080 |
Why?
|
Insulin-Like Growth Factor I | 1 | 2016 | 2014 | 0.080 |
Why?
|
Receptors, Immunologic | 1 | 2015 | 1423 | 0.080 |
Why?
|
Lymphocyte Activation | 1 | 2019 | 5519 | 0.080 |
Why?
|
Follow-Up Studies | 10 | 2023 | 39004 | 0.080 |
Why?
|
Remission Induction | 1 | 2014 | 2384 | 0.080 |
Why?
|
Wound Healing | 1 | 2019 | 2781 | 0.080 |
Why?
|
Species Specificity | 1 | 2012 | 2479 | 0.080 |
Why?
|
Immunohistochemistry | 4 | 2021 | 11363 | 0.080 |
Why?
|
Software | 2 | 2013 | 4434 | 0.080 |
Why?
|
Public Health | 1 | 2021 | 2594 | 0.080 |
Why?
|
Central Nervous System | 1 | 2015 | 1354 | 0.080 |
Why?
|
Glucose | 1 | 2020 | 4391 | 0.080 |
Why?
|
Aged | 18 | 2023 | 162944 | 0.080 |
Why?
|
Antibodies, Bacterial | 1 | 2013 | 1469 | 0.070 |
Why?
|
Sulfonamides | 1 | 2016 | 1932 | 0.070 |
Why?
|
Single-Cell Analysis | 1 | 2017 | 2183 | 0.070 |
Why?
|
Fatty Acids, Omega-3 | 1 | 2016 | 1341 | 0.070 |
Why?
|
Microglia | 1 | 2015 | 1261 | 0.070 |
Why?
|
Fetal Blood | 1 | 2013 | 1317 | 0.070 |
Why?
|
Middle Aged | 20 | 2021 | 213127 | 0.070 |
Why?
|
Peptides | 1 | 2019 | 4392 | 0.070 |
Why?
|
Dopamine | 1 | 2014 | 1589 | 0.070 |
Why?
|
GTP-Binding Proteins | 1 | 2011 | 970 | 0.070 |
Why?
|
Carcinoma, Pancreatic Ductal | 1 | 2017 | 1631 | 0.070 |
Why?
|
Gene Expression | 1 | 2019 | 7790 | 0.070 |
Why?
|
RNA Interference | 1 | 2015 | 2890 | 0.070 |
Why?
|
Interleukin-2 Receptor alpha Subunit | 1 | 2007 | 310 | 0.070 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2016 | 2276 | 0.070 |
Why?
|
Carcinoma, Adenoid Cystic | 1 | 2008 | 252 | 0.070 |
Why?
|
Energy Metabolism | 2 | 2015 | 2896 | 0.070 |
Why?
|
Vulvar Neoplasms | 1 | 2008 | 272 | 0.070 |
Why?
|
Bone and Bones | 1 | 2016 | 2575 | 0.070 |
Why?
|
Leukocytes | 1 | 2013 | 2039 | 0.060 |
Why?
|
Class I Phosphatidylinositol 3-Kinases | 2 | 2022 | 890 | 0.060 |
Why?
|
Staphylococcus aureus | 1 | 2013 | 1449 | 0.060 |
Why?
|
Muscle, Skeletal | 1 | 2020 | 4933 | 0.060 |
Why?
|
Bacterial Infections | 1 | 2013 | 1389 | 0.060 |
Why?
|
Adult | 17 | 2021 | 213712 | 0.060 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 2010 | 2638 | 0.060 |
Why?
|
United States | 10 | 2021 | 69693 | 0.060 |
Why?
|
Proportional Hazards Models | 4 | 2021 | 12344 | 0.060 |
Why?
|
Lymphocyte Count | 2 | 2016 | 792 | 0.060 |
Why?
|
Melanoma | 1 | 2021 | 5462 | 0.060 |
Why?
|
Malaria | 1 | 2013 | 1232 | 0.060 |
Why?
|
Signal Transduction | 3 | 2016 | 23387 | 0.060 |
Why?
|
Quantitative Trait Loci | 1 | 2011 | 2015 | 0.060 |
Why?
|
Fluorescein-5-isothiocyanate | 1 | 2003 | 225 | 0.050 |
Why?
|
Neutrophils | 1 | 2015 | 3711 | 0.050 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2017 | 5163 | 0.050 |
Why?
|
Genomics | 2 | 2019 | 5692 | 0.050 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 2 | 2022 | 1683 | 0.050 |
Why?
|
Cell Movement | 1 | 2014 | 5212 | 0.050 |
Why?
|
Prebiotics | 1 | 2021 | 44 | 0.050 |
Why?
|
Risk Factors | 8 | 2021 | 72145 | 0.050 |
Why?
|
Clinical Trials, Phase II as Topic | 1 | 2023 | 627 | 0.050 |
Why?
|
Amniotic Fluid | 1 | 2023 | 366 | 0.050 |
Why?
|
Computational Biology | 1 | 2013 | 3518 | 0.050 |
Why?
|
Interleukin-13 Receptor alpha1 Subunit | 1 | 2020 | 24 | 0.050 |
Why?
|
Coated Pits, Cell-Membrane | 1 | 2000 | 78 | 0.050 |
Why?
|
Pinocytosis | 1 | 2000 | 65 | 0.050 |
Why?
|
Pancreatic Neoplasms | 1 | 2017 | 5249 | 0.040 |
Why?
|
Clinical Trials, Phase III as Topic | 1 | 2023 | 839 | 0.040 |
Why?
|
Eicosapentaenoic Acid | 1 | 2023 | 582 | 0.040 |
Why?
|
Oxidoreductases | 1 | 2001 | 424 | 0.040 |
Why?
|
Alkylation | 1 | 2019 | 86 | 0.040 |
Why?
|
Proto-Oncogene Proteins B-raf | 2 | 2022 | 2028 | 0.040 |
Why?
|
Cell Line | 4 | 2020 | 15994 | 0.040 |
Why?
|
Clathrin | 1 | 2000 | 265 | 0.040 |
Why?
|
HT29 Cells | 1 | 2019 | 200 | 0.040 |
Why?
|
Myoblasts | 1 | 2020 | 238 | 0.040 |
Why?
|
Rectus Abdominis | 1 | 2019 | 94 | 0.040 |
Why?
|
Alkylating Agents | 1 | 2019 | 139 | 0.040 |
Why?
|
Bacteroides | 1 | 2019 | 161 | 0.040 |
Why?
|
Melanoma, Experimental | 1 | 2021 | 559 | 0.040 |
Why?
|
Protein Binding | 3 | 2016 | 9387 | 0.040 |
Why?
|
Sequence Analysis, DNA | 3 | 2016 | 4801 | 0.040 |
Why?
|
Mycoplasma hyorhinis | 1 | 2017 | 8 | 0.040 |
Why?
|
Salmonella typhimurium | 1 | 2000 | 351 | 0.040 |
Why?
|
Gammaproteobacteria | 1 | 2017 | 28 | 0.040 |
Why?
|
Antigen-Presenting Cells | 1 | 2001 | 969 | 0.040 |
Why?
|
Enzyme Activation | 2 | 2003 | 3701 | 0.040 |
Why?
|
Gene Knock-In Techniques | 1 | 2019 | 418 | 0.040 |
Why?
|
Carrier Proteins | 1 | 2011 | 5019 | 0.040 |
Why?
|
Paneth Cells | 1 | 2017 | 100 | 0.040 |
Why?
|
Mammals | 1 | 2023 | 1135 | 0.040 |
Why?
|
Health Personnel | 2 | 2021 | 3210 | 0.040 |
Why?
|
Spiroplasma | 1 | 2016 | 3 | 0.040 |
Why?
|
Chronic Disease | 2 | 2022 | 9144 | 0.040 |
Why?
|
Specific Pathogen-Free Organisms | 1 | 2016 | 226 | 0.040 |
Why?
|
Fluorescent Antibody Technique | 1 | 2021 | 2505 | 0.040 |
Why?
|
Physical Conditioning, Animal | 1 | 2020 | 362 | 0.040 |
Why?
|
Allergy and Immunology | 1 | 2018 | 169 | 0.030 |
Why?
|
Kaplan-Meier Estimate | 2 | 2018 | 6534 | 0.030 |
Why?
|
Burkina Faso | 1 | 2016 | 88 | 0.030 |
Why?
|
Genitalia, Male | 1 | 2016 | 84 | 0.030 |
Why?
|
Enterocytes | 1 | 2017 | 225 | 0.030 |
Why?
|
Ribotyping | 1 | 2015 | 35 | 0.030 |
Why?
|
Cohort Studies | 4 | 2021 | 40450 | 0.030 |
Why?
|
Time Factors | 4 | 2021 | 40054 | 0.030 |
Why?
|
Ecology | 1 | 2016 | 105 | 0.030 |
Why?
|
Diet Surveys | 1 | 2020 | 1172 | 0.030 |
Why?
|
Proteomics | 2 | 2022 | 3618 | 0.030 |
Why?
|
Mutation | 5 | 2020 | 29717 | 0.030 |
Why?
|
Insect Vectors | 1 | 2016 | 134 | 0.030 |
Why?
|
Running | 1 | 2020 | 478 | 0.030 |
Why?
|
Cell Membrane | 2 | 2002 | 3744 | 0.030 |
Why?
|
Molecular Epidemiology | 1 | 2017 | 468 | 0.030 |
Why?
|
Risk | 2 | 2019 | 9679 | 0.030 |
Why?
|
Genitalia, Female | 1 | 2016 | 146 | 0.030 |
Why?
|
Virulence Factors | 1 | 2019 | 509 | 0.030 |
Why?
|
Colectomy | 1 | 2020 | 681 | 0.030 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2007 | 4379 | 0.030 |
Why?
|
Bacterial Toxins | 1 | 2000 | 933 | 0.030 |
Why?
|
Oxidation-Reduction | 1 | 2020 | 2187 | 0.030 |
Why?
|
Age of Onset | 1 | 2021 | 3266 | 0.030 |
Why?
|
Antigens, Neoplasm | 1 | 2002 | 1983 | 0.030 |
Why?
|
Reproducibility of Results | 2 | 2023 | 19862 | 0.030 |
Why?
|
Cell Differentiation | 3 | 2017 | 11470 | 0.030 |
Why?
|
Placenta | 1 | 2023 | 1694 | 0.030 |
Why?
|
Tissue Array Analysis | 1 | 2015 | 553 | 0.030 |
Why?
|
Biopsy | 2 | 2017 | 6756 | 0.030 |
Why?
|
Opsonin Proteins | 1 | 2013 | 150 | 0.030 |
Why?
|
Microbial Viability | 1 | 2014 | 234 | 0.030 |
Why?
|
Plasmodium | 1 | 2016 | 248 | 0.030 |
Why?
|
Child | 2 | 2021 | 77478 | 0.030 |
Why?
|
Weight Gain | 1 | 2023 | 2282 | 0.030 |
Why?
|
Down-Regulation | 1 | 2000 | 3001 | 0.030 |
Why?
|
Multivariate Analysis | 2 | 2017 | 12242 | 0.030 |
Why?
|
HeLa Cells | 1 | 2019 | 3127 | 0.030 |
Why?
|
Risk Assessment | 3 | 2021 | 23320 | 0.030 |
Why?
|
Paraffin Embedding | 1 | 2013 | 299 | 0.030 |
Why?
|
Prognosis | 3 | 2018 | 29010 | 0.030 |
Why?
|
RNA, Bacterial | 1 | 2014 | 391 | 0.030 |
Why?
|
Gram-Positive Bacteria | 1 | 2013 | 184 | 0.030 |
Why?
|
Inflammation Mediators | 1 | 2021 | 1889 | 0.030 |
Why?
|
Body Weight | 1 | 2023 | 4664 | 0.030 |
Why?
|
Bacterial Capsules | 1 | 2013 | 251 | 0.030 |
Why?
|
Plasmodium berghei | 1 | 2013 | 168 | 0.030 |
Why?
|
Bacterial Outer Membrane Proteins | 1 | 2015 | 404 | 0.030 |
Why?
|
Neoplasms, Experimental | 1 | 2017 | 1274 | 0.030 |
Why?
|
Logistic Models | 2 | 2018 | 13403 | 0.030 |
Why?
|
Intestine, Large | 1 | 2011 | 71 | 0.030 |
Why?
|
Nutritive Value | 1 | 2015 | 339 | 0.030 |
Why?
|
Genome-Wide Association Study | 1 | 2011 | 12220 | 0.030 |
Why?
|
Smad Proteins | 1 | 2012 | 162 | 0.030 |
Why?
|
Organoids | 1 | 2017 | 692 | 0.030 |
Why?
|
Gram-Negative Bacteria | 1 | 2013 | 270 | 0.020 |
Why?
|
Nurses | 1 | 2021 | 2459 | 0.020 |
Why?
|
Databases, Factual | 2 | 2017 | 7716 | 0.020 |
Why?
|
Kinetics | 2 | 2014 | 6474 | 0.020 |
Why?
|
Fungi | 1 | 2013 | 327 | 0.020 |
Why?
|
Population Surveillance | 1 | 2021 | 2616 | 0.020 |
Why?
|
Saliva | 1 | 2014 | 805 | 0.020 |
Why?
|
Viral Proteins | 1 | 2017 | 1899 | 0.020 |
Why?
|
Double-Blind Method | 1 | 2023 | 12017 | 0.020 |
Why?
|
Phenotype | 2 | 2019 | 16331 | 0.020 |
Why?
|
Osteogenesis | 1 | 2016 | 1299 | 0.020 |
Why?
|
C-Reactive Protein | 1 | 2021 | 3766 | 0.020 |
Why?
|
Gene Expression Profiling | 2 | 2017 | 9410 | 0.020 |
Why?
|
Sensitivity and Specificity | 2 | 2017 | 14720 | 0.020 |
Why?
|
Forkhead Transcription Factors | 1 | 2016 | 1613 | 0.020 |
Why?
|
Immunologic Factors | 1 | 2018 | 1575 | 0.020 |
Why?
|
Endosomes | 2 | 2002 | 520 | 0.020 |
Why?
|
Polymorphism, Genetic | 1 | 2019 | 4328 | 0.020 |
Why?
|
Immunocompromised Host | 1 | 2013 | 847 | 0.020 |
Why?
|
Health Status | 1 | 2021 | 4030 | 0.020 |
Why?
|
Alleles | 1 | 2019 | 6931 | 0.020 |
Why?
|
Peptide Fragments | 1 | 2000 | 5095 | 0.020 |
Why?
|
Viruses | 1 | 2011 | 374 | 0.020 |
Why?
|
Hydrogen-Ion Concentration | 2 | 2003 | 2552 | 0.020 |
Why?
|
Sex Factors | 1 | 2021 | 10392 | 0.020 |
Why?
|
Proteins | 1 | 2002 | 6096 | 0.020 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2023 | 9941 | 0.020 |
Why?
|
Bone Morphogenetic Proteins | 1 | 2012 | 838 | 0.020 |
Why?
|
Massachusetts | 1 | 2020 | 8662 | 0.020 |
Why?
|
Adipose Tissue | 2 | 2016 | 3278 | 0.020 |
Why?
|
Antioxidants | 1 | 2015 | 1659 | 0.020 |
Why?
|
Exercise | 1 | 2023 | 5611 | 0.020 |
Why?
|
Nutritional Status | 1 | 2015 | 1606 | 0.020 |
Why?
|
Diarrhea | 1 | 2013 | 1343 | 0.020 |
Why?
|
Vitamins | 1 | 2015 | 1608 | 0.020 |
Why?
|
Data Mining | 1 | 2011 | 537 | 0.020 |
Why?
|
Cells, Cultured | 4 | 2003 | 19223 | 0.020 |
Why?
|
Killer Cells, Natural | 1 | 2015 | 2133 | 0.020 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2015 | 2938 | 0.020 |
Why?
|
Blood Glucose | 1 | 2020 | 6249 | 0.020 |
Why?
|
Aged, 80 and over | 2 | 2021 | 57683 | 0.020 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2023 | 9185 | 0.020 |
Why?
|
Membrane Proteins | 1 | 2002 | 7873 | 0.020 |
Why?
|
Age Factors | 1 | 2021 | 18355 | 0.020 |
Why?
|
Genotype | 1 | 2019 | 12946 | 0.010 |
Why?
|
Survival Rate | 1 | 2018 | 12773 | 0.010 |
Why?
|
Lipopolysaccharides | 2 | 2003 | 2211 | 0.010 |
Why?
|
Polymerase Chain Reaction | 1 | 2013 | 6171 | 0.010 |
Why?
|
Iron | 1 | 2012 | 1773 | 0.010 |
Why?
|
Transcription, Genetic | 1 | 2017 | 7721 | 0.010 |
Why?
|
Biopsy, Fine-Needle | 1 | 2008 | 1093 | 0.010 |
Why?
|
Horseradish Peroxidase | 1 | 2003 | 166 | 0.010 |
Why?
|
Bone Marrow Cells | 1 | 2011 | 2513 | 0.010 |
Why?
|
Models, Genetic | 1 | 2013 | 3493 | 0.010 |
Why?
|
Odds Ratio | 1 | 2015 | 9846 | 0.010 |
Why?
|
Tetanus Toxoid | 1 | 2003 | 193 | 0.010 |
Why?
|
Quality of Life | 1 | 2023 | 12730 | 0.010 |
Why?
|
Serum Albumin, Bovine | 1 | 2003 | 324 | 0.010 |
Why?
|
Oxidoreductases Acting on Sulfur Group Donors | 1 | 2001 | 32 | 0.010 |
Why?
|
Microscopy, Video | 1 | 2002 | 245 | 0.010 |
Why?
|
Cathepsins | 1 | 2003 | 239 | 0.010 |
Why?
|
Vacuolar Proton-Translocating ATPases | 1 | 2003 | 195 | 0.010 |
Why?
|
DNA Methylation | 1 | 2015 | 4282 | 0.010 |
Why?
|
Immunoglobulin G | 1 | 2013 | 4554 | 0.010 |
Why?
|
Ovalbumin | 1 | 2003 | 719 | 0.010 |
Why?
|
Pregnancy | 1 | 2023 | 29087 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2017 | 15056 | 0.010 |
Why?
|
Antibodies, Monoclonal | 2 | 2013 | 9274 | 0.010 |
Why?
|
Liver | 1 | 2016 | 7470 | 0.010 |
Why?
|
Obesity | 1 | 2023 | 12705 | 0.010 |
Why?
|
Neoplasm Staging | 1 | 2015 | 11001 | 0.010 |
Why?
|
Antigens, CD | 2 | 2002 | 4024 | 0.010 |
Why?
|
Solubility | 1 | 2002 | 1083 | 0.010 |
Why?
|
Hybridomas | 1 | 2001 | 452 | 0.010 |
Why?
|
Antigens, CD34 | 1 | 2002 | 657 | 0.010 |
Why?
|
Thiazolidines | 1 | 2000 | 74 | 0.010 |
Why?
|
Cysteine Endopeptidases | 1 | 2003 | 563 | 0.010 |
Why?
|
Membrane Glycoproteins | 2 | 2002 | 3769 | 0.010 |
Why?
|
Survival Analysis | 1 | 2013 | 10248 | 0.010 |
Why?
|
Cell Line, Tumor | 1 | 2016 | 16665 | 0.010 |
Why?
|
Models, Biological | 1 | 2016 | 9581 | 0.010 |
Why?
|
Disulfides | 1 | 2001 | 457 | 0.010 |
Why?
|
Computer Simulation | 1 | 2013 | 6191 | 0.010 |
Why?
|
Research Design | 1 | 2015 | 5979 | 0.010 |
Why?
|
Rats | 1 | 2016 | 24265 | 0.010 |
Why?
|
Protein Subunits | 1 | 2003 | 960 | 0.010 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2016 | 8925 | 0.010 |
Why?
|
Stem Cells | 2 | 2002 | 3563 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2015 | 10472 | 0.010 |
Why?
|
Mice, Inbred C3H | 1 | 2000 | 964 | 0.010 |
Why?
|
Protein Folding | 1 | 2001 | 843 | 0.010 |
Why?
|
Immunophenotyping | 1 | 2002 | 1866 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2023 | 62966 | 0.010 |
Why?
|
Immunization | 1 | 2001 | 1255 | 0.010 |
Why?
|
Young Adult | 1 | 2023 | 56350 | 0.010 |
Why?
|
Protein Transport | 1 | 2002 | 1988 | 0.010 |
Why?
|
Antigens | 1 | 2001 | 1462 | 0.010 |
Why?
|
Biological Transport | 1 | 2000 | 2119 | 0.010 |
Why?
|
Spleen | 1 | 2001 | 2359 | 0.010 |
Why?
|
Epitopes | 1 | 2001 | 2569 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2015 | 24913 | 0.010 |
Why?
|
Histocompatibility Antigens Class I | 1 | 2000 | 1366 | 0.010 |
Why?
|
Protein Conformation | 1 | 2001 | 4013 | 0.010 |
Why?
|
Ligands | 1 | 2000 | 3293 | 0.010 |
Why?
|
Thiazoles | 1 | 2000 | 1484 | 0.010 |
Why?
|
Monocytes | 1 | 2002 | 2593 | 0.010 |
Why?
|
Algorithms | 1 | 2013 | 13853 | 0.010 |
Why?
|
Receptors, Antigen, T-Cell | 1 | 2000 | 2524 | 0.010 |
Why?
|
Nose Deformities, Acquired | 1 | 1971 | 44 | 0.010 |
Why?
|
Ear, External | 1 | 1971 | 160 | 0.010 |
Why?
|
Amino Acid Sequence | 1 | 2001 | 13814 | 0.010 |
Why?
|
Infant | 1 | 2011 | 35070 | 0.010 |
Why?
|
Nose Neoplasms | 1 | 1971 | 245 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 2001 | 18112 | 0.010 |
Why?
|
Nose | 1 | 1971 | 509 | 0.000 |
Why?
|
Cartilage | 1 | 1971 | 818 | 0.000 |
Why?
|
B-Lymphocytes | 1 | 2000 | 4664 | 0.000 |
Why?
|
Skin Transplantation | 1 | 1971 | 1074 | 0.000 |
Why?
|
Tomography, X-Ray Computed | 1 | 2008 | 20086 | 0.000 |
Why?
|
Keratoacanthoma | 1 | 1971 | 32 | 0.000 |
Why?
|
Pigmentation Disorders | 1 | 1971 | 101 | 0.000 |
Why?
|
Transplantation, Autologous | 1 | 1971 | 2123 | 0.000 |
Why?
|
Carcinoma, Basal Cell | 1 | 1971 | 545 | 0.000 |
Why?
|
Adolescent | 1 | 1971 | 85649 | 0.000 |
Why?
|